Asia Executives To Watch: Takeda Turns To Local Talent In Changing China
As China moves to implement a raft of planned policy and regulatory changes, including opening up more to new drugs from multinationals, companies including Takeda appear to be ringing in personnel changes and increasingly hiring local executives to senior positions.
You may also be interested in...
From bringing innovative new drugs to global markets, to record-setting fundraisings and initial public offerings, five trends are emerging in China's health sector that are worth closely watching in 2021.
One year after the first cases of a novel coronavirus emerged in Wuhan, a team from the World Health Organization has arrived in the city to investigate its origin. Meanwhile, mixed results are reported for some of the leading Chinese vaccines being developed to fight the pandemic still wreaking global havoc.
China's innovative drug makers step into the spotlight by grabbing green lights for cancer drugs in the country's latest batch of product approvals.